Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Arnica Montana
Therapeutic Area : Undisclosed
Study Phase : Phase IV
Recipient : Center for Clinical and Cosmetic Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Arnica montana is a Other Large Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
July 30, 2013
Lead Product(s) : Arnica Montana
Therapeutic Area : Undisclosed
Highest Development Status : Phase IV
Recipient : Center for Clinical and Cosmetic Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Pimecrolimus
Therapeutic Area : Dermatology
Study Phase : Phase IV
Recipient : Emer, Jason, M.D.
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Pimecrolimus is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Dermatitis, Atopic.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 09, 2010
Lead Product(s) : Pimecrolimus
Therapeutic Area : Dermatology
Highest Development Status : Phase IV
Recipient : Emer, Jason, M.D.
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
